CTNM · Contineum Therapeutics, Inc.
$17.20
+1.18 (+7.37%)
At close · Aug 21
Market Cap
$602.69M
Shares
37.62M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-30 | — | |
| 10-Q | 2026-07-30 | 2026-06-30 | |
| 8-K | 2026-07-13 | — | |
| 8-K | 2026-06-26 | — | |
| Investor Event Transcript | 2026-06-09 | 2026-06-30 | |
| 10-Q | 2026-05-05 | 2026-03-31 | |
| 8-K | 2026-05-05 | — | |
| DEF 14A | 2026-04-30 | 2026-06-26 | |
| 8-K | 2026-04-30 | — | |
| 10-K | 2026-03-05 | 2025-12-31 | |
| 8-K | 2026-03-05 | — | |
| 8-K | 2026-01-26 | 2026-01-23 | |
| 8-K | 2025-12-15 | 2025-12-11 | |
| 8-K | 2025-12-11 | 2025-12-08 | |
| 8-K | 2025-11-20 | — | |
| 10-Q | 2025-10-30 | 2025-09-30 | |
| 8-K | 2025-10-30 | — | |
| 8-K | 2025-09-18 | — | |
| 8-K | 2025-08-05 | — | |
| 10-Q | 2025-08-05 | 2025-06-30 | |
| 8-K | 2025-06-26 | — | |
| 8-K | 2025-05-14 | — | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| DEF 14A | 2025-04-29 | 2025-06-26 | |
| 8-K | 2025-04-28 | — | |
| 8-K | 2025-03-17 | 2025-03-14 | |
| 10-K | 2025-03-06 | 2024-12-31 | |
| 8-K | 2025-03-06 | — | |
| 8-K | 2024-11-06 | — | |
| 10-Q | 2024-11-06 | 2024-09-30 | |
| 8-K/A | 2024-08-14 | 2024-08-13 | |
| 10-Q | 2024-08-14 | 2024-06-30 | |
| 8-K | 2024-08-13 | — | |
| 8-K | 2024-06-24 | 2024-06-21 | |
| 8-K | 2024-05-31 | 2024-05-24 | |
| 8-K | 2024-05-20 | — | |
| 8-K | 2024-05-16 | — | |
| 10-Q | 2024-05-16 | 2024-03-31 | |
| 8-K | 2024-04-09 | — |
Showing 1–39 of 39 filings
Key facts
CIK
1855175
CUSIP
21217B100
13F (30d)
99 filings
97 filers
Visit website
Investor relations